Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Role of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes of Head-and-Neck Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00184860
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : April 27, 2007
Sponsor:
Information provided by:
Radboud University

Brief Summary:

Technical developments in radiation oncology are making it possible to deliver a prescribed radiation dose to radiation target volume with increasing accuracy.

Therefore it is becoming even more relevant to accurately define the radiation target volumes.

The current standard in defining radiation target volumes in patients with head-and-neck cancer is to combine physical examination data with a CT-scan in the treatment position.

The goal of this investigation is to analyse the rol of CT-PET-MRI image fusion in defining radiation target volumes.


Condition or disease Intervention/treatment Phase
Head and Neck Neoplasms Procedure: PET-scan, MRI-scan Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 80 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Value of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes in Patients With a Squamous Cell Carcinoma of the Head-and-Neck Region, Who Are to be Treated With Definitive Radiotherapy
Study Start Date : June 2003

Resource links provided by the National Library of Medicine






Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Patients eligible for definitive radiotherapy with a Head and Neck Neoplasm (squamous cell carcinoma) in one of the following anatomical sites:

  • oral cavity
  • oropharynx
  • hypopharynx
  • larynx

Exclusion Criteria:

  • age < 18 years
  • pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00184860


Locations
Layout table for location information
Netherlands
Radboud University Nijmegen Medical Centre
Nijmegen, Gelderland, Netherlands, 6500HB
Sponsors and Collaborators
Radboud University
Investigators
Layout table for investigator information
Study Director: Johannes H Kaanders, MD. PhD Radiation oncologist, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00184860    
Other Study ID Numbers: 2004/153
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: April 27, 2007
Last Verified: April 2007
Additional relevant MeSH terms:
Layout table for MeSH terms
Head and Neck Neoplasms
Neoplasms by Site
Neoplasms